Related Experiment Video
Updated: Oct 6, 2025
Measuring Global Cellular Matrix Metalloproteinase and Metabolic Activity in 3D Hydrogels
Published on: January 22, 2019
Integration of a miniaturized DMMB assay with high-throughput screening for identifying regulators of proteoglycan
Yi Sun1, Yuen-Kee Tsui1, Mengqi Yu1,2
1Department of Orthopaedics and Traumatology, The University of Hong Kong, Hong Kong, China.
Abstract:
Defective biosynthesis or function of proteoglycans causes pathological conditions in a variety of tissue systems. Osteoarthritis (OA) is a prevalent degenerative joint disorder characterized by progressive cartilage destruction caused by imbalanced proteoglycan synthesis and degradation. Identifying agents that regulate proteoglycan metabolism may benefit the development of OA-modifying therapeutics. High-throughput screening (HTS) of chemical libraries has paved the way for achieving this goal. However, the implementation and adaptation of HTS assays based on proteoglycan measurement remain underexploited. Using primary porcine chondrocytes as a model, we report a miniaturized dimethyl-methylene blue (DMMB) assay, which is commonly used to quantitatively evaluate sulfated glycosaminoglycan (GAG) content, with an optimized detection range and reproducibility and its integration with HTS. Treatment with TGF-β1 and IL1-α, known as positive and negative proteoglycan regulators, respectively, supported the assay specificity. A pre-test of chemical screening of 960 compounds identified both stimulators (4.48%) and inhibitors (6.04%) of GAG production. Fluorophore-assisted carbohydrate electrophoresis validated the activity of selected hits on chondroitin sulfate expression in an alginate culture system. Our findings support the implementation of this simple colorimetric assay in HTS to discover modifiers of OA or other diseases related to dysregulated proteoglycan metabolism.
Insights
This study optimized a dimethyl-methylene blue (DMMB) assay for high-throughput screening (HTS) to identify compounds regulating proteoglycan metabolism, crucial for osteoarthritis (OA) therapeutics.
Area of Science:
- Biochemistry
- Biotechnology
- Cell Biology
Background:
- Proteoglycan dysfunction underlies various diseases, including osteoarthritis (OA), a degenerative joint disorder.
- Imbalanced proteoglycan synthesis and degradation drive OA pathogenesis, necessitating therapeutic targets.
- Discovering agents that modulate proteoglycan metabolism is key for developing OA-modifying treatments.
Purpose of the Study:
- To develop and validate a miniaturized, high-throughput screening (HTS) assay for measuring proteoglycan (sulfated glycosaminoglycan) levels.
- To adapt the dimethyl-methylene blue (DMMB) colorimetric assay for HTS applications using primary chondrocytes.
- To identify novel chemical compounds that regulate proteoglycan metabolism for potential OA therapies.
Main Methods:
- A miniaturized dimethyl-methylene blue (DMMB) assay was optimized for quantitative sulfated glycosaminoglycan (GAG) measurement in primary porcine chondrocytes.
- Assay specificity was confirmed using known proteoglycan regulators: TGF-β1 (stimulator) and IL1-α (inhibitor).
- High-throughput screening of 960 compounds was performed, followed by validation of hit compounds using fluorophore-assisted carbohydrate electrophoresis on chondroitin sulfate expression.
Main Results:
- The optimized DMMB assay demonstrated enhanced detection range and reproducibility for HTS implementation.
- Screening identified 4.48% of compounds as GAG production stimulators and 6.04% as inhibitors.
- Selected compounds showed validated activity on chondroitin sulfate expression in an alginate culture model.
Conclusions:
- The developed DMMB-based HTS assay is a robust tool for discovering modulators of proteoglycan metabolism.
- This assay can accelerate the identification of therapeutic agents for osteoarthritis and other diseases linked to proteoglycan dysregulation.
- The findings support the broader adoption of this colorimetric assay in drug discovery pipelines.
More Related Videos
11:31Establishment of a High-throughput Setup for Screening Small Molecules That Modulate c-di-GMP Signaling in Pseudomonas aeruginosa
Published on: June 30, 2016
10:49Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models
Published on: June 16, 2022